Drug Type Gene therapy |
Synonyms |
Target |
Mechanism Chk1 inhibitors(Checkpoint kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Boundless Bio, Inc.Startup |
Active Organization Boundless Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain metastases | Preclinical | US | Boundless Bio, Inc.Startup | 22 Nov 2023 |
Glioblastoma | Preclinical | US | Boundless Bio, Inc.Startup | 22 Nov 2023 |